R. Islam

916 total citations
8 papers, 725 citations indexed

About

R. Islam is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, R. Islam has authored 8 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in R. Islam's work include HER2/EGFR in Cancer Research (3 papers), Medical Imaging Techniques and Applications (2 papers) and Peptidase Inhibition and Analysis (2 papers). R. Islam is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Medical Imaging Techniques and Applications (2 papers) and Peptidase Inhibition and Analysis (2 papers). R. Islam collaborates with scholars based in United States, Italy and United Arab Emirates. R. Islam's co-authors include Kristine Broglio, Ana M. González-Angulo, Gabriel N. Hortobágyi, Massimo Cristofanilli, G. N. Hortobágyi, T. Yu, Shaheenah Dawood, Francisco J. Esteva, Shu‐Wan Kau and Paolo Morandi and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

R. Islam

8 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Islam United States	7	531	277	207	132	97	8	725
Nishan Tchekmedyian United States	10	522 1.0×	400 1.4×	297 1.4×	172 1.3×	73 0.8×	17	795
W. H. Miller United States	9	486 0.9×	166 0.6×	283 1.4×	88 0.7×	104 1.1×	17	723
M. Beeram United States	16	452 0.9×	304 1.1×	406 2.0×	169 1.3×	165 1.7×	48	860
H. A. Burris United States	17	534 1.0×	218 0.8×	271 1.3×	92 0.7×	119 1.2×	57	770
Kaori Fujimoto-Ouchi United States	15	552 1.0×	283 1.0×	242 1.2×	101 0.8×	241 2.5×	28	823
Jean Powers Canada	9	330 0.6×	265 1.0×	420 2.0×	209 1.6×	56 0.6×	12	748
Noah Goodman United States	10	381 0.7×	275 1.0×	116 0.6×	103 0.8×	76 0.8×	12	646
A. Lambiase Italy	17	613 1.2×	181 0.7×	297 1.4×	92 0.7×	146 1.5×	55	899
Ivor Percent United States	13	412 0.8×	299 1.1×	371 1.8×	155 1.2×	56 0.6×	33	715
Sharon Wilks United States	16	688 1.3×	405 1.5×	272 1.3×	236 1.8×	125 1.3×	49	950

Countries citing papers authored by R. Islam

Since Specialization

Citations

This map shows the geographic impact of R. Islam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Islam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Islam more than expected).

Fields of papers citing papers by R. Islam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Islam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Islam. The network helps show where R. Islam may publish in the future.

Co-authorship network of co-authors of R. Islam

This figure shows the co-authorship network connecting the top 25 collaborators of R. Islam. A scholar is included among the top collaborators of R. Islam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Islam. R. Islam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Hamaoka, Tsuyoshi, Colleen M. Costelloe, John E. Madewell, et al.. (2010). Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer. British Journal of Cancer. 102(4). 651–657. 69 indexed citations

Cabıoğlu, Neslihan, Ayşegül A. Şahin, Paolo Morandi, et al.. (2009). Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications. Annals of Oncology. 20(6). 1013–1019. 65 indexed citations

Dawood, Shaheenah, Kristine Broglio, Francisco J. Esteva, et al.. (2009). Survival among women with triple receptor-negative breast cancer and brain metastases. Annals of Oncology. 20(4). 621–627. 129 indexed citations

Dawood, Shaheenah, Kristine Broglio, Francisco J. Esteva, et al.. (2008). Defining prognosis for women with breast cancer and CNS metastases by HER2 status. Annals of Oncology. 19(7). 1242–1248. 154 indexed citations

Cristofanilli, Massimo, Paolo Morandi, James M. Reuben, et al.. (2008). Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: clinical activity and biological correlations. Annals of Oncology. 19(10). 1713–1719. 75 indexed citations

Cabıoğlu, Neslihan, Yun Yun Gong, R. Islam, et al.. (2007). Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer. Annals of Oncology. 18(6). 1021–1029. 117 indexed citations

González-Angulo, Ana M., James M. Reuben, Daniel J. Booser, et al.. (2006). Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits. Annals of Oncology. 17(5). 813–817. 113 indexed citations

Hamaoka, Tsuyoshi, John E. Madewell, Colleen M. Costelloe, et al.. (2005). Accurate response assessment of breast cancer bone metastasis using computed tomography and new response criteria. Journal of Clinical Oncology. 23(16_suppl). 568–568. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact